Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00471224 · ClinicalTrials.gov registry record
A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product
A clinical trial of Siderosis, sponsored by Pfizer.
- Completed
- Registry status
- 16
- Enrollment target
- 3
- Study locations
NCT00471224: Completed study of Siderosis, sponsored by Pfizer.
NCT00471224 is a study of Siderosis that has completed, run by Pfizer. The registered enrollment target is 16 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00471224, a study of Siderosis, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 3
- Study locations
Study Summary
This protocol intends to detail investigations necessary to evaluate the ocular safety of subjects enrolled in study A4321001 and who have received formulated Drug Product (Lot 8716-098).
Conditions Studied
Interventions
- OTHER Observational Trial
Study Locations (3)
Massachusetts
- Pfizer Investigational Site - Boston
North Carolina
- Pfizer Investigational Site - Charlotte
Texas
- Pfizer Investigational Site - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-11 |
What the finished NCT00471224 record still lists
NCT00471224 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 1 condition, with Siderosis appearing as the primary indexed condition, and to 1 intervention - of which Observational Trial is the first listed.
NCT00471224 reports a single indexed study location in Massachusetts, North Carolina, Texas.
Frequently Asked Questions
What is clinical trial NCT00471224 about?
NCT00471224 is a clinical study titled "A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product". This protocol intends to detail investigations necessary to evaluate the ocular safety of subjects enrolled in study A4321001 and who have received formulated Drug Product (Lot 8716-098).
What is the current status of trial NCT00471224?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2007-06. Estimated completion is 2008-11.
What conditions does trial NCT00471224 study?
This clinical trial studies the following conditions: Siderosis.
What interventions are being tested in trial NCT00471224?
The interventions under investigation include: Observational Trial (OTHER).
Who is sponsoring clinical trial NCT00471224?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00471224 being conducted?
This trial has 3 study locations across Massachusetts, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia